Amiodarone is the most widely prescribed antiarrhythmic drug worldwide, but induces
thyrotoxicosis or hypothyroidism in 15% to 20% of patients. Hyperthyroidism is less frequent …

Amiodarone-induced thyrotoxicosis (AIT) is less common than amiodarone-induced
hypothyroidism, but is more likely to pose a diagnostic and management challenge. It has …

Context Amiodarone-induced thyrotoxicosis (AIT) is a difficult diagnostic and management
challenge, especially during severe thyrotoxicosis accompanied by cardiovascular …

Amiodarone-induced thyrotoxicosis is often poorly tolerated owing to underlying cardiac
disease, and frequently resistant to medical therapy. We describe a 48-year-old patient with …

The principal management of Amiodarone-induced-thyrotoxicosis (AIT) is balancing cardiac-
thyroid conditions. However, the role of thyroidectomy is still contentious. This systematic …

Introduction Amiodarone is a widely used anti-arrhythmic drug. A common long-term
complication is amiodarone-induced thyrotoxicosis (AIT). We examined retrospectively the …

Background Amiodarone is a potent antiarrhythmic medication, and its use is known to be
associated with thyroid dysfunction. The most worrisome dysfunction is amiodarone-induced …

OBJECTIVE: Amiodarone can cause thyroid dysfunction in patients with or without previous
thyroid disease. With increased use from its placement in advanced cardiac life support …

Fewer than 100 cases of amiodarone-induced thyrotoxicosis (AIT) managed surgically have
been reported worldwide. This study aims to assess the outcome of thyroidectomy under …

Amiodarone, a benzofuranic iodine-rich pan-anti-arrhythmic drug, induces amiodarone-
induced thyrotoxicosis (AIT) in 7–15% of patients. AIT is a major issue due to its typical …